Breakthrough Protein-Making Technology Could Cut Biotech Costs
What Happened
The University of Kent has launched a start-up called Sirius Proteins to commercialize a new protein-production technology. The company's Vesicle Nucleating Peptide (VNp) platform helps bacteria package and release proteins more efficiently, potentially making proteins used in cancer treatments, vaccines and diagnostic tests cheaper and easier to produce.
Key Takeaways
By simplifying protein production and purification, the technology could reduce costs for researchers and biotech firms, helping accelerate the development of cancer therapies, diagnostics and other medical innovations.